Keywords: قطار; α-TOS; α-tocopheryl succinate; BAP1; BRCA1 associated protein-1; BRCA1; breast cancer susceptibility gene 1; CDK4; cyclin-dependent kinase 4; CEA; carcinoembryonic antigen; CSC(s); cancer stem(-like) cell(s); CTGF; connective tissue growth factor (CCN2)
مقالات ISI قطار (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: قطار; Crystalline lens; Ionizing radiation; DNA repair factors; Nontargeted effects; Inflammation; Tumor suppressors; A-bomb; atomic-bomb; Acvr1; activin A type 1 receptor; AP; apurinic/apyrimidinic; APE1; apurinic/apyrimidinic endonuclease 1; AQP; aquaporin; A
Keywords: قطار; Antioxidant; Anti-proliferative; Apoptosis; Dahlia variabilis; Diabetes mellitus; Polyphenol; ADP; adenosine diphosphate; BDE; bond dissociation energy; BHT; butylated hydroxytoluene; COX; cyclooxygenase; DPPH; diphenyl-2-picrylhydrazyl; EGFR; epidermal g
Keywords: قطار; Human serum albumin; Nanoparticles; Inhalation; TRAIL; Self-assembly; Resistant lung cancer;
Keywords: قطار; Lipid rafts; Signal transduction; IGF-I/PI3K/Akt signaling; Fas/CD95; CASMER; Cancer; APL; alkylphospholipid analogue; CASMER; cluster of apoptotic signaling molecule-enriched rafts; DED; death effector domain; DD; death domain; DISC; death-inducing signa
Keywords: قطار; AMPK; AMP-activated protein kinase; DISC; death-inducing signaling complex; DMSO; dimethyl sulfoxide; mp; melting point; MTS; 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium); NMR; nuclear magnetic resonance; ppm;
Keywords: قطار; 5-ALA; 5-aminolevulinic acid; 5-FU; 5-fluorouracil; APC; antigen presenting cell; BCC; basal cell carcinoma; CAP; cold atmospheric plasma; CM; cutaneous malignant melanoma; CNP; cerium oxide nanoparticle; CNT; carbon nanotube; COX-2; cyclooxygenase II; CP
Keywords: قطار; AG-I; type I arabinogalactan; AG-II; type II arabinogalactan; ASGP-R; asialoglycoprotein receptor; CP; citrus pectin; CRD; carbohydrate recognition domain; CSDDS; colon-specific drug delivery system; DF; dietary fiber; DM; degree of methylation; DR; death
Keywords: قطار; BM; bone marrow; BMDC; bone marrow derived cells; BMT; bone marrow transplant; MCT; monocrotaline; SuHx; sugen 5416 & hypoxia; OPG; osteoprotegerin; PAH; pulmonary arterial hypertension; PASMC; pulmonary artery smooth muscle cell; PCNA; proliferating cell
Keywords: قطار; Vascular targeting; Tumor necrosis factor superfamily; F8 antibody; TRAIL; FasL;
Keywords: قطار; Melatonin (PubChem CID: 896); Bortezomib (PubChem CID: 387447); Melatonin; Proteasome; Apoptosis; Bax; Bim; Bcl-2; Tumor suppressor p53; Nuclear factor kappa beta; Caspase 3; Caspase 9; TRAIL;
Keywords: قطار; Child abuse; Substance-related disorders; TNF; TWEAK; TRAIL; Cytokines; Inflammation;
Keywords: قطار; PCA; principle component analysis; PCA1; first principal axis; PCA2; second principal axis; OR; odds ratio; HR; hazard ratio; AIC; Akaike information criterion; hsCRP; high sensitivity C-reactive protein; IFN-γ; interferon-γ; IL; interleukin; MCP; monoc
Keywords: قطار; Graph partition; Matching on a circle; Matching algorithm; Trail; Computational geometry; Image analysis
Keywords: قطار; Breast cancer; TLR; TNF; TRAIL; TRAF2; Survival; Cigarettes; Oxidative stress;
Keywords: قطار; Trail; Greenway; American Indian; Quality of life; Community development; Indian Country;
Keywords: قطار; ADAM; (a disintegrin and metalloprotease) metallopeptidase; ALPs; alkyl-lysophospholipids; CD24; signal transducer CD24 (glycosylphosphatidylinositol-anchored receptor); CD44; CD44 antigen (receptor for hyaluronic acid); CXCR4; chemokine receptor type 4;
Keywords: قطار; AD; Alzheimer's disease; Aβ; amyloid beta; CDK5; cyclin-dependent kinase 5; CNS; central nervous system; COX; cyclooxygenase; CRP; C-reactive protein; FADD; Fas-Associated protein with Death Domain; GSK3; glycogen synthase kinase-3; IFN-γ; interferon-γ
Keywords: قطار; Habitat modification; Non-native species; Road; Trail; Perpetuation of tourism impacts; Spatial extent
Keywords: قطار; Persistent Viral Infection; Immune Exhaustion; Co-Inhibitory Molecules; T-cell Immunity; Bim; BCL-2 interacting mediator of cell death; HBV; hepatitis B virus; HCV; hepatitis C virus; IFN; interferon; IL; interleukin; iMATE; intrahepatic myeloid cell aggr
Keywords: قطار; 5-ALA; 5-amino-levulinic acid; RGD; arginine-glycine-aspartic acid; BBB; blood-brain barrier; BCNU; carmustine; CASANT; carmustine sustained-release implant; CNS; central nervous system; CED; convection-enhanced delivery; c(RGDyK); cyclic arginineâ
Keywords: قطار; Apoptosis; Necrosis; Necroptosis; Necrosome; DAMP; Viral Hepatitis; NASH; Clinical Trial; Hepatocellular Carcinoma; Alcoholic Liver Disease; DILI; Caspases; RIP3; RIP Kinases; ALD; alcoholic liver disease; ALT; alanine aminotransferase; AST; aspartate ami
Keywords: قطار; Cardiovascular disease; Hemodialysis; Infection; Mortality; TRAIL;
Keywords: قطار; FBS; fetal bovine serum; CTF; carboxyl-terminal fragment; ICD; intracellular domain; RIP; regulated intramembrane proteolysis; PS; presenilin; ADAM; a disintegrin and metalloprotease; TAPI; tumor necrosis factor-α protease inhibitor; TRAIL; TNF-related a
Keywords: قطار; Cytokines; Inflammation; Macrophage migration-inhibitory factors; Rehabilitation; Spinal cord injuries; AIS; American Spinal Injury Association Impairment Scale; CTACK; cutaneous T cell-attracting chemokine; GROα; growth-related oncogene alpha; HGF; he
Keywords: قطار; ADCC; antibody dependent cell cytotoxicity; Apaf-1; apoptosis-activating factor 1; BID; BH3-interacting domain; CAD; caspase-activated DNase; CMV; cytomegalovirus; DC; dendritic cell; DLN; draining lymph node; FasL; Fas ligand; FADD; Fas-associated protei
Keywords: قطار; Aldh1a1; aldehyde dehydrogenase family 1 member A1; Bax; Bcl2-associated X protein; BNF; β-naphthoflavone; Col1a1; collagen, type I, alpha 1; Cox-2; cyclooxygenase 2; Cu; copper; Cxcl10; chemokine (C-X-C motif) ligand 10; Cx3cl1; chemokine (C-X3-C motif)
Keywords: قطار; ALP; alkylphospholipid; ASK1; apoptosis signal-regulating kinase 1; CT; CTP:phosphocholine cytidylyltransferase; DISC; death-inducing signaling complex; EGF; epidermal growth factor; ER; endoplasmic reticulum; ERK; extracellular-signal-regulated kinase; J
Keywords: قطار; Abl; Abelson leukemia proto-oncogene; ADAP; adhesion and degranulation promoting adapter protein (Fyb, SLAP-130); Asc; apoptosis-associated speck-like protein containing a CARD; BCR; B-cell receptor; C3G; Crk SH3 domain-binding guanine nucleotide exchange
Keywords: قطار; BH; Bcl-2 homology; CA; cholic acid (3α,7α,12α-trihydroxy-5β-cholanoic acid); CDCA; chenodeoxycholic acid (3α,7α-dihydroxy-5β-cholanoic acid); DCA; deoxycholic acid (3α,12α-dihydroxy-5β-cholanoic acid); EGFR; epidermal growth factor receptor; ER
Keywords: قطار; siRNA; small interfering RNA; AON; antisense oligonucleotides; shRNA; small hairpin RNA; pDNA; plasmid DNA; CYP3A; cytochrome P450 3A; MDR; multidrug resistance; MDR1; multidrug resistance protein 1; Pgp; P-glycoprotein; TRAIL; tumor necrosis factor-relat
Keywords: قطار; Monitoring; Camera trap; Protected area management; Recreation; Trail;
Keywords: قطار; AAV; adeno-associated viruses; Ad; adenovirus; CTGVT; cancer targeting gene-viro-therapy; EGFR; epidermal growth factor receptor; EPCs; endothelial precursor cells; GAOVT; gene armed oncolytic virus therapy; GCV; ganciclovir; HRE; hypoxia responsive eleme
LncRNA HOXA-AS2 and its molecular mechanisms in human cancer
Keywords: قطار; lncRNA; HOXA-AS2; Diagnosis; Therapeutic target; Prognosis; APL; Acute promyelocytic leukemia; ATRA; All trans retinoic acid; Bax; BCL2-Associated X; BC; Breast cancer; Bcl-2; B-cell lymphoma-2; c-Myc; MYC proto-oncogene; CRC; Colorectal cancer; DDIT3; DN
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study
Keywords: قطار; TRAIL; Early preeclampsia; IUGR; Doppler anomalies; Cardiovascular risk;
Interferon α subtypes in HIV infection
Keywords: قطار; AIDS; acquired immune deficiency syndrome; APOBEC3G; apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G; ART; antiretroviral therapy; BLT; bone marrow-liver-thymus; Dpi; days post infection; HIV; human immunodeficiency virus; IDO; indoleam
MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1
Keywords: قطار; TRAIL; tumor necrosis factor (TNF-related apoptosis-inducing ligand; FOXA1; Forkhead box protein A1; NSCLL; Non-small cell lung cancer; miR-760; TRAIL; FOXA1; NSCLC; Apoptosis;
Gambogic acid sensitizes breast cancer cells to TRAIL-induced apoptosis by promoting the crosstalk of extrinsic and intrinsic apoptotic signalings
Keywords: قطار; TRAIL; Gambogic acid; Breast cancer; Apoptosis; Resistance;
Combination of novel DR5 targeting agonistic scFv antibody TR2-3 with cisplatin shows enhanced synergistic antitumor activity in vitro and in vivo
Keywords: قطار; DR5; death receptor 5; DR4; death receptor 4; TNF; tumor necrosis factor; TRAIL; TNF-related apoptosis inducing ligand; scFv; single chain fragment variable; MTT; methyl thazoy terazolium; IPTG; isopropyl β-D-1-thiogalactopyranoside; PBS; phosphate buffe
Role of Forkhead Box O (FOXO) transcription factor in aging and diseases
Keywords: قطار; FOXO; Forkhead box O; DBD; DNA-binding domain; NLS; Nuclear localization sequence; NES; Nuclear export sequence; IRE; Insulin-responsive element; ARDs; Age-related diseases; RTK; Receptor tyrosine kinase; PI3K; Phosphoinositide 3kinase; SGK; Serum and glu
Embryotoxic cytokines-Potential roles in embryo loss and fetal programming
Keywords: قطار; Embryo; Cytokines; TNF; IFNG; TRAIL; Stress response; Apoptosis;
Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
Keywords: قطار; CC; cancer cell; CMBNPS; cell membrane-based nanoparticles; CTC; circulating tumor cell; DOX; doxorubicin; DSPE; distearoyl phosphoethanolamine; EPR; enhanced permeability and retention; ICG; indocyanine green; NIR; near infrared; NPs; nanoparticles; PLGA
Comprehensive expression analysis of TNF-related apoptosis-inducing ligand and its receptors in colorectal cancer: Correlation with MAPK alterations and clinicopathological associations
Keywords: قطار; TRAIL; Apoptosis; mRNA expression; Real time RT-PCR; Colorectal cancer;
Efficacy of ONC201 in Desmoplastic Small Round Cell Tumor
Keywords: قطار; DR4/DR5; Death Receptors; DSRCT; Desmoplastic Small Round Cell Tumor; TRAIL; TNF-related apoptosis inducing ligand;
The combination of TRAIL and MG-132 induces apoptosis in both TRAIL-sensitive and TRAIL-resistant human follicular lymphoma cells
Keywords: قطار; TRAIL; MG-132; Bcl-2 family proteins; XIAP; Follicular lymphoma; Caspases;
The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia
Keywords: قطار; TRAIL; TNF-related apoptosis-inducing ligand; XIAP; X-linked inhibitor of apoptosis protein; cFLIP; cellular FLICE-inhibitory protein; bcl-2; B-cell lymphoma 2; IAP; inhibitor of apoptosis proteins; Mcl-1; myeloid cell leukemia-1; Apo-2L; Apo2 ligand; DR;
Antihypertensive drug-candesartan attenuates TRAIL resistance in human lung cancer via AMPK-mediated inhibition of autophagy flux
Keywords: قطار; Candesartan; Autophagy; TRAIL; Apoptosis; Lung cancer cells; DR5; AMPK;
Aminoacyl-tRNA synthetases, therapeutic targets for infectious diseases
Keywords: قطار; ARS; aminoacyl-tRNA synthetase; TLR; toll-like receptor; RIG-I; retinoic acid-inducible gene-I; MAVS; mitochondrial antiviral signaling protein; IFN; interferon; ITCH; E3 ubiquitin-protein ligase Itchy homolog; MSC; multi-tRNA synthetase complex; AIMP; AR
ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication
Keywords: قطار; ADAR1; adenosine deaminase acting on RNA 1; AGS; Aicardi-Goutières syndrome; APOBEC3; apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3; ds; double-stranded; dsRBD; dsRNA binding domains; eIF2α; translation initiation factor2; HIV-1; hum
Re-evaluating the role of FOXOs in cancer
Keywords: قطار; RTK; receptor tyrosine kinase; GF; growth factor; PI3K; Phosphatidylinositol-4,5-bisphosphate 3-kinase; PKB; protein kinase B; AKT; RAC-alpha serine/threonine-protein kinase; FOXO; forkhead box O; GFR; growth factor receptor; PDPK1; Phosphoinositide-depen